Clinical Trial Update: Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study) [NA]

View source ↗

Summary

This clinical trial update notes a study evaluating the WeFlow-EndoPatch System for distal entry tear repair in aortic dissection, with status not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection
• Distal Entry Tear

Drugs mentioned

• WeFlow-EndoPatch System

Snippet

Sponsor: Hangzhou Endonom Medtech Co., Ltd. | Conditions: Aortic Dissection, Distal Entry Tear | NA | Status: NOT_YET_RECRUITING